Allograft inflammatory factor-1 (AIF-1) is an evolutionary conserved, inflammatory protein produced by activated macrophages during chronic transplant rejection and in inflammatory brain lesions. Since T-cell-mediated inflammation is common to various dermatoses and nothing is known about AIF-1 in skin, we studied its protein expression at the tissue level and regulation in monocytic cell lines by various agents. Using immunohistochemistry, we found that AIF-1 is expressed at low levels in normal skin, but is highly upregulated in various inflammatory skin disorders, such as psoriasis, lichen planus, graft-versus-host disease and mycosis fungoides. The main cell types expressing AIF-1 in affected skin are macrophages and Langerhans' cells. We also show by real-time PCR that AIF-1 mRNA levels in monocytic THP-1 and U937 cell lines are significantly upregulated by retinoic acid as well as a number of cytokines. We conclude that AIF-1 may mediate survival and pro-inflammatory properties of macrophages in skin diseases. © 2007 Acta Dermato-Venereologica.
CITATION STYLE
Orsmark, C., Skoog, T., Jeskanen, L., Kere, J., & Saarialho-Kere, U. (2007). Expression of allograft inflammatory factor-1 in inflammatory skin disorders. Acta Dermato-Venereologica, 87(3), 223–227. https://doi.org/10.2340/00015555-0225
Mendeley helps you to discover research relevant for your work.